Roche has launched a new injection-based lung cancer treatment in India that can be given in just seven minutes. The therapy, called Tecentriq SC, is used for certain patients with non-small cell lung cancer and is administered under the skin instead of through a long IV drip.
Doctors said the shorter treatment time could reduce hospital waiting hours and make cancer care more comfortable for patients. The treatment is mainly suitable for patients with high PD-L1 levels. Roche said patient support programmes will help improve access, as the therapy remains expensive.